HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Small Business Matters

HBW Insight’s coverage of news and issues impacting small and mid-sized enterprises.



Digital Home-Testing Is The Future, Says Bloom Diagnostics Co-Founder Angelica Kohlmann

With its lateral flow at-home tests for ferritin, thyroid function and ovarian reserves, Swiss medtech firm Bloom Diagnostics thinks it has seen the future of consumer healthcare. HBW Insight speaks to co-founder and board chair Angelica Kohlmann about the firm's Bloom Lab technology and forward-looking plans, including a possible US launch. 

Plantwise Launches Supplement Line Focusing On 'Specialized Retailers'

Plantwise launched its CBD supplements in independent pharmacies in May with consultation consumers might not receive at larger chains.

Hot Flash! Menopause May Not Be Sexy, But Investors Are Warming To Digital Health Solutions

Menopause market is a multi-billion opportunity gaining traction with digital health companies offering solutions to help women manage their symptoms and provide treatment and support. Medtech Insight spoke with three female founders and entrepreneurs, as well as a partner at Lux Capital and clinical lead of ORCHA, about this market. 

Public TV Channel Investment Shows UK CBD Market 'Normalizing'

UK public service TV network Channel 4 says its investment in Cannaray will help bring CBD to the mainstream and shows the country's CBD market is stabilizing.

Arcaea CEO On Biotech’s Promise: Sustainable, Yes, But Ingredient Performance Will Drive Adoption

With biotech, “the entire tree of life starts to become accessible to us ethically and sustainably,” says Arcaea CEO Jasmina Aganovic. Her company, launched in October 2021, is developing custom keratin molecules for skin and hair, as well as new UV filter technology, among other innovations to expand formulators’ toolkits, not just replace problematic ingredients.

'Could Put Us Out Of Business’: US State Bill Pileup Has Small Beauty Set On Federal Preemption

The cosmetics industry has an “optics” problem, and that is creating other issues, namely a growing body of state legislation to address perceived gaps in federal regulatory oversight.

HBW Insight’s Key Takeaways From 2021: #3 Keep Your Eye On AI

The future of digital health will be shaped more than anything else by the rise of artificial intelligence. From body enhancing bio-wearables to camera-based skin diagnostics, the consumer health industry continued to explore the possibilities presented by AI in 2021. However, there are many regulatory and ethical hurdles industry must overcome as we move into 2022 and beyond.

Beauty Firms Hit With Prop 65 Notice: Don’t Ignore Or Retailers May ‘Blackball’ You

Ballard Spahr attorney Brendan Collins warned attendees to take Prop 65 violation notices seriously and address them in a timely manner, speaking at the Independent Beauty Association’s 2022 Technical Regulatory Forum.

Independent Beauty Association Maintains Watch On Global Supply Chain In 2022

US demand for personal-care and cosmetic products continues to exceed the capacities of an industry fraught with supply-chain pressures, according to Independent Beauty Association leadership.

Independent Beauty Association Apprehensive About Patchwork of State Recycling Bills

Extended producer responsibility legislation passed last year in Maine and Oregon and is being considered in other states, including New Jersey and Hawaii as of January 2022. The Independent Beauty Association is concerned about a patchwork of laws forming across the US that would significantly challenge small and mid-sized companies.

Study Suggests Futura’s Drug-Free Erectile Dysfunction Gel Suitable For US OTC Pathway

The successful completion of a short, non-clinical, human factors study puts Futura Medical's MED3000 erectile dysfunction gel one step closer to OTC device approval in the US.

Stada's Nature's Aid Launches Sustainable Supplements In UK, Frustrated At CBD Delays

HBW Insight catches up with Nature's Aid managing director Chris Morrey to talk about the firm's new sustainable dietary supplment range, Wild Earth, as well as the challenges posed by the UK's new regulstory regime for CBD novel foods. 

UsernamePublicRestriction

Register